Skip to main content
. 2020 Mar 24;13:605–612. doi: 10.2147/JPR.S237833

Figure 4.

Figure 4

Difference of proportion of responders by eGFR at baseline (COMPOSE-1/COMPOSE-2 intent-to-treat population).

Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; NAL, naldemedine; PBO, placebo; RI, renal impairment.